Is Palantir Stock a Buy Right Now?

Palantir shares have risen from $10 at its direct listing six years ago to about $186, supported by adoption of its Gotham and Foundry platforms and growing AI demand. Analysts expect 2025–2028 revenue and EPS CAGRs of 59% and 70%, respectively, but the stock trades at 87 times next year's earnings. The article flags rising rates and Treasury yields, reputational concerns, and overlapping services from Snowflake and Databricks as risks; the author would wait for a better macro environment.

Analysis

The key risk is not whether AI adoption continues, but whether Palantir converts deployments into durable, repeatable commercial growth fast enough to support a valuation with substantial execution already embedded. Higher real yields can compress the multiple before fundamentals roll over; a rate-driven drawdown therefore is not, by itself, evidence the product thesis has weakened. Conversely, strong headline AI demand is not enough: monitor commercial customer expansion, deal conversion and remaining performance obligations for evidence of monetization rather than pilot activity.

Competitive pressure is likely to emerge at the data layer. Snowflake and Databricks can be credible alternatives where customers prefer modular infrastructure or want to limit dependence on one platform. That can constrain pricing and renewals even without a direct one-for-one substitute. Palantir’s government exposure may offer a different demand driver, but geopolitical demand is lumpy and carries reputational and procurement risks; it should not be treated as a guaranteed offset to commercial weakness.

Near term, rate moves and positioning may dominate. Over 1–3 months, estimate revisions and commercial conversion matter more than broad AI announcements. Over 6–18 months, the test is whether customers expand usage and whether competitive alternatives cap economics. The contrarian opportunity is to separate a duration-driven multiple reset from deteriorating execution; the opposing risk is that optimistic growth assumptions leave little room for even modest misses.

Key Decisions for Investors

• Avoid chasing PLTR after sharp moves; consider staged exposure only if Treasury yields stabilize and upcoming results show commercial expansion translating into contracted or recognized revenue. Reassess if commercial growth or forward guidance decelerates materially.
• Treat PLTR as a long-duration growth exposure: size against a further valuation contraction, and avoid interpreting a yield-driven decline as a buy signal without confirming operating metrics.
• Put SNOW and Databricks on a competitive watchlist. Look for customer wins, renewal commentary, or pricing evidence that indicates substitution—not just overlapping product claims—before expressing a relative-value position.
• Do not short PLTR solely on the stated valuation or rising-rate risk. A short thesis needs confirmation from estimate cuts, weaker commercial conversion, or evidence that customer expansion is slowing; otherwise upside from continued execution creates meaningful squeeze risk.